Related Experiment Video

Updated: Jul 16, 2026

Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri

Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri

Published on: September 12, 2025

Late bleeding problems with the levonorgestrel-releasing intrauterine system: evaluation of the endometrial cavity

Maria Rönnerdag¹, Viveka Odlind

¹Department of Women's and Children's Health, University of Uppsala, S 75267 Uppsala, Sweden. Maria.ronnerdag@comhem.se

|March 17, 2007

Abstract

Background:

This study was conducted to determine causes of abnormal bleeding patterns occurring after at least 6 months of successful use of the levonorgestrel-releasing intrauterine system (LNG-IUS).

Study Design:

Matched-pair, case-control study. Fifteen users of the device with unacceptable bleeding problems (cases) and 15 controls using the device but without such problems were recruited. All women had vaginal ultrasonography and hysteroscopy performed to evaluate the endometrial cavity.

Results:

An abnormality demonstrated by ultrasonography or hysteroscopy (either device displacement or leiomyomas) was more common among cases than controls. The McNemar's test for discordant case-control pairs yielded a p value of .046. After removal of the device and reinsertion of another levonorgestrel-releasing device, all cases reported improvement of the bleeding pattern.

Conclusions:

Displacement of the device and intracavitary leiomyomas are commonly associated with unacceptable bleeding in women after prolonged use of the LNG-IUS. Ultrasonography and hysteroscopy may be useful in evaluating bleeding complaints in long-term users of this device.

Related Concept Videos

Intrauterine Drug Delivery Systems

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

Menses Phase

Menses Phase

The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...

Ovarian Cycle

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...

Birth Control Methods

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...

Articles linked to this work by shared authors, journal, and citation graph.

Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.

Human reproduction (Oxford, England)·2005

See all related articles